MetaTOC stay on top of your field, easily

'The waiting game': are current chlamydia and gonorrhoea near-patient/point-of-care tests acceptable to service users and will they impact on treatment?

, , ,

International Journal of STD & AIDS: Clinical practice in sexual health

Published online on

Abstract

Objective

Assessing the time service users are prepared to wait for chlamydia and gonorrhoea (CT/GC) near-patient/point-of-care test (NP-POCT) results and to determine possible effect on management.

Method

Individuals attending two UK clinics from November 2013 to February 2014 were surveyed asking the maximum time they would wait for CT/GC NP-POCT results after consultation. Linked CT/GC prevalence and treatment rates were analysed.

Results

A total of 1817 participants were surveyed, and 1356 provided CT/GC NAAT samples in which it was found that 115 (8.5%) could wait over 90 min in clinic for their result, 115 received treatment at consultation, of whom 50 were CT/GC negative, and of whom 12 were treated for urethritis or cervicitis and 38 attended as CT/GC contacts. Six of this population would have waited over 90 min were NP-POCTs available. A total of 129 tested CT/GC positive, of whom 65 were treated at their consultation, 61 at a later date, and 3 were untreated. Also 12 pf 129 would wait over 90 min for a NP-POCT result.

Conclusion

It is concluded that 90-min NP-POCTs are not acceptable to most clinic attendees and would not have impacted on treatment rates or inappropriate prescribing, and 20-min NP-POCTs show a marginal benefit in treating CT/GC. While NP-POCTs for CT/GC are promising, they must meet client expectations and enhance disease management to be accepted by patients and clinicians.